|
Active Ingredient
|
ALPROSTADIL
|
|
Therapeutic Class
|
VASODILATING AGENTS, MISCELLANEOUS
|
|
Indications
|
Congenital heart disease in neonates until surgery is possible.
|
|
Caution
|
Infants: apnoea, fever, flushing, hypotension, bradycardia, tachycardia, diarrhoea, and convulsions.
|
|
Dose Range
|
Pediatric: Continuous intravenous infusion, initially 5 nanograms /kg/ minute, adjusted according to response, adjusted in steps of 5 nanograms/ kg / minute ( max . Per dose 100 nanograms /kg/minute),
|
|
Drug Interactions
|
|
|
Pregnancy
|
|
|
Breast Feeding
|
|
